Knowledge Center
Patent / Jan 11, 2024
Dry powder inhaler pharmaceutical composition of coated crystalline dry powder for inhalation
Source:
WO 2024009079 A1
The present invention describes a dry powder inhaler pharmaceutical composition comprising one or more active pharmaceutical ingredients (API) coated with one or more force control agents (FCA) with optimized aerodynamic performance by micronizing crystalline API particles to the respirable range and coating the particles with a force control agent. The present invention also id pharmaceutical composition, and its use in medicine.
Ìý
Also in the Knowledge Center
/ Nov 16, 2020
Liquid-Liquid Extractions in API Manufacturing Processes: Is Continuous the Way to Go?
Read more
Scientific Article
/ Nov 16, 2020
Inverse Gas Chromatography (IGC) of Pharmaceutical Powders: Harnessing the Power of Adhesion-Cohesion Forces to Improve Pharmaceutical Development
Read more
Scientific Article
Scientific Article